Evaluation of the Safety and Efficacy of Dehydrated Human Placenta Tissue (dHPT) for Wound Healing
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCellution Biologics
About this trial
The retrospective trial is observational, intended to stand alone, complement and integrate data collected in ongoing clinical studies to aid in establishing payor coverage in the United States (U.S.) for Cellution Biologics allograft products with real-world evidence to support the clinical adoption in patients to manage chronic or surgical wounds.
Eligibility criteria
Qualifiers
18 years of age or older.
Wound treated with Cellution Biologics AmchoPlast, a dehydrated human placental tissue (dHPT).
Wound present for greater than or equal to 30 days prior to treatment with dHPT.
Wound is not infected.
Disqualifiers
AmchoPlast dHPT product was not applied to wound.
HbA1C >12%.
Presence of active osteomyelitis.
Concurrent treatment for malignant disease.
Trial design
Treatments tested in this trial
- dHPT, AIC
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov